Overinvested in NAB shares? Here are 2 alternative ASX 200 shares

There are some blue chips I'd rather buy than NAB.

| More on:
Couple looking at their phone surprised, symbolising a bargain buy.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

sdf

National Australia Bank Ltd (ASX: NAB) shares were a great investment in 2024, delivering a rise of more than 22%. However, with those gains, some shareholders may feel the portion of their portfolio invested in the ASX bank stock has grown too large and they'd prefer to allocate some of the gains elsewhere.

But what sorts of businesses would be good investments right now for NAB shareholders?

If I were looking to reallocate some of my gains from NAB shares, I would diversify away from the banking sector and instead put the investment money towards some different S&P/ASX 200 Index (ASX: XJO) sector opportunities.

So, let's take a look at two ASX shares outside the banking sector that could be attractive for potentially faster growth and less competition than NAB.

Sonic Healthcare Ltd (ASX: SHL)

NAB makes a large proportion of its earnings in Australia, so it could be useful to diversify by looking at a business with major earnings outside of Australia. There's also a risk to NAB earnings in the near term with the potential for rising mortgage arrears among its customers amid high interest rates and inflation. It may also be a good idea to consider a defensive ASX 200 stock to help counteract that threat.

Sonic Healthcare is a global pathology business. The ASX healthcare share has a presence in the United States, Australia, Germany, Switzerland, the United Kingdom, Belgium, and New Zealand.

The company plays an important part in the healthcare systems of the countries it operates in. Since we don't choose when we get sick, demand is fairly consistent throughout economic cycles.

This ASX 200 stock is seeing steady and long-term revenue growth from tailwinds in its operating countries, including ageing and growing populations. It wasn't surprising to me that Sonic's total revenue grew 10% in the first four months of FY25 – much stronger than what owners of NAB shares are seeing.

Sonic Healthcare is expecting operating profit (EBITDA) to grow by around 10% in FY25. Earnings growth looks positive in the coming years, with recent acquisitions, easing cost inflation and increasing usage of technology/artificial intelligence (AI) throughout the business to boost productivity.

The company has grown its dividend every year for the past decade and has a current dividend yield of around 3.8%.

REA Group Ltd (ASX: REA)

Owning NAB shares is a big bet on the Australian economy and largely the Australian property market. If investors want to profit from Australia's property market, another option outside of NAB would be to invest in the business that owns realestate.com.au.

REA Group's real estate portal receives an average of 132.4 million realestate.com.au monthly visits, four times more than its nearest competitor. That market strength allows the ASX 200 stock to increase listing prices regularly with little detriment.

The FY25 first quarter update highlighted the company's ability to grow revenue at a decent pace and for profit to rise even faster — quarterly revenue rose 21% to $413 million and operating profit (EBITDA) increased 23% to $236 million.

It also appears the company is experiencing similar success in India, which obviously has a much larger population than that of Australia and, therefore, greater potential. The FY25 first quarter saw revenue growth of 42% year over year in that market thanks to strong growth in adjacency services, as well as continued momentum on Housing.com.

Motley Fool contributor Tristan Harrison has positions in REA Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Hand holding Australian dollar (AUD) bills, symbolising ex dividend day. Passive income.
Growth Shares

Where to invest $5,000 in ASX shares for growth

These shares could be top picks for investors looking for growth opportunities.

Read more »

A happy young woman in a red t-shirt hold up two delicious burritos.
Growth Shares

I think these 2 exciting ASX growth shares are buys today

These compelling investments have a great outlook.

Read more »

Happy man working on his laptop.
Growth Shares

EOFY 2025: 3 ASX 200 shares to buy for the year ahead

Looking for quality picks for the next financial year? Here are three quality picks that analysts rate as buys.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Growth Shares

Macquarie tips nearly 50% upside for this ASX 200 stock

Let's see which stock the broker is feeling bullish about this week.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Growth Shares

3 excellent ASX 200 growth shares brokers rate as buys

Let's see why they think investors should be snapping them up right now.

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Growth Shares

Why I think these 2 ASX shares are ideal for growth investors

These investments are very compelling.

Read more »

Two brokers analysing the share price with the woman pointing at the screen and man talking on a phone.
Growth Shares

2 ASX shares highly recommended to buy: Experts

Analysts really like these stocks. Here’s why…

Read more »

Three happy office workers cheer as they read about good financial news on a laptop.
Growth Shares

5 ASX growth shares to buy and hold

Analysts think these shares could be top picks for investors looking for growth options.

Read more »